Two Sigma Investments LP Acquires Shares of 14,793 Astrana Health, Inc. (NASDAQ:ASTH)

Two Sigma Investments LP acquired a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 14,793 shares of the company's stock, valued at approximately $466,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ASTH. Pilgrim Partners Asia Pte Ltd acquired a new stake in Astrana Health in the fourth quarter valued at approximately $40,000. Quarry LP boosted its stake in Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after acquiring an additional 471 shares in the last quarter. KBC Group NV boosted its stake in Astrana Health by 108.4% in the fourth quarter. KBC Group NV now owns 2,530 shares of the company's stock valued at $80,000 after acquiring an additional 1,316 shares in the last quarter. US Bancorp DE boosted its stake in Astrana Health by 3,880.0% in the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after acquiring an additional 4,656 shares in the last quarter. Finally, Pictet Asset Management Holding SA boosted its stake in Astrana Health by 21.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock valued at $223,000 after acquiring an additional 1,273 shares in the last quarter. 52.77% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on ASTH. Stifel Nicolaus lowered their target price on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Bank of America lowered their target price on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research note on Tuesday, March 4th. Robert W. Baird lowered their target price on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Barclays assumed coverage on shares of Astrana Health in a research note on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price objective for the company. Finally, Truist Financial lowered their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Astrana Health currently has an average rating of "Moderate Buy" and an average target price of $53.29.

Astrana Health Stock Performance

Shares of NASDAQ:ASTH traded down $0.60 on Friday, hitting $25.75. 212,743 shares of the company were exchanged, compared to its average volume of 292,738. Astrana Health, Inc. has a 1-year low of $23.12 and a 1-year high of $63.20. The stock's 50 day moving average price is $28.71 and its 200 day moving average price is $32.39. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $1.44 billion, a P/E ratio of 19.81, a price-to-earnings-growth ratio of 1.37 and a beta of 0.85.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The business had revenue of $620.39 million for the quarter, compared to analyst estimates of $628.11 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company's revenue for the quarter was up 53.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.31 earnings per share. Sell-side analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.